Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 28, 2012; 18(8): 736-745
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.736
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.736
Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
Jie-Er Ying, Li-Ming Zhu, Bi-Xia Liu, Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China
Author contributions: Ying JE, Zhu LM and Liu BX contributed equally to this work; Ying JE and Zhu LM designed the paper; Ying JE wrote the pape; and Liu BX collected the material.
Correspondence to: Jie-Er Ying, Associate Chief Physician, Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang Province, China. jieerying@yahoo.cn
Telephone: +86-571-88122162 Fax: +86-571-88122515
Received: May 29, 2011
Revised: August 26, 2011
Accepted: September 3, 2011
Published online: February 28, 2012
Revised: August 26, 2011
Accepted: September 3, 2011
Published online: February 28, 2012
Core Tip